Satsuma Pharmaceuticals, Inc. SEC Filings

Filed On	Filing
20 Jun 2023	15-12G
13 Jun 2023	NONE
12 Jun 2023	Form 4: Ra Capital MANAGEMENT, L.p., Former 10% Owner and 2 others Disposed of 5,914,252 shares (Tender Offer) · Disposed of 60,000 Stock Option (Right to Buy) (Disposition to Issuer)
12 Jun 2023	SC 13D/A
08 Jun 2023	EFFECT
08 Jun 2023	EFFECT
08 Jun 2023	EFFECT
08 Jun 2023	Form 4: O'Neil Thomas P., Chief Financial Officer Disposed of 13,877 shares (Tender Offer) ($12.6K) · Disposed of 478,935 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Shah Rajeev M., Director Disposed of 5,914,252 shares (Tender Offer) ($5.38M) · Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Takanashi Ken, Director Bought 22,053,581 shares ($20.1M) · Disposed of 60,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Riebe Michael T, Director Disposed of 100,423 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Sandoval Elisabeth, Director Disposed of 74,893 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Soloway Thomas P, Director Disposed of 70,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Kollins John A, Director Disposed of 305,911 shares (Tender Offer) ($278K) · Disposed of 1,579,572 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Lukatch Heath, Director Disposed of 70,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: King Thomas Braxton, Director Disposed of 100,423 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	Form 4: Shin Nippon Biomedical Laboratories, Ltd., 10% owner Bought 22,053,581 shares ($20.1M) · Bought 8,423,732 shares ($7.67M)
08 Jun 2023	Form 4: Harsch Mutya, Director Disposed of 70,000 Stock Option (right to buy) (Disposition to Issuer)
08 Jun 2023	25-NSE
08 Jun 2023	S-8 POS

Comments